U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915168) titled 'CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer' on March 11.
Brief Summary: This clinical trial studies how well a chemotherapy-induced peripheral neuropathy (CIPN) decision aid works in improving chemotherapy decision making among patients with breast cancer. CIPN involves numbness or tingling in the hands or feet and is a debilitating side effect of several commonly used classes of cancer drugs. CIPN symptoms are typically minor at first but can progress with continued treatment to severe symptoms that can affect long-term function, falls risk, and quality of life. Symptoms som...